Aceclofenac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H13Cl2NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RPK779R03H, chemically known as 2-(o-(2,6-dichloranilino)phenylacetoxy)essigsaeure but generally known as aceclofenac, which bears US NIH Compound Identifier 71771. European Medicines Agency schedules Aceclofenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05200MIG. The term ACECLOFENAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules aceclofenac in its Anatomical Therapeutic Chemical (ATC) Classification. ACECLOFENAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aceclofenac under HS 29224995 and SITC 51465. As of Q4 2014, ACECLOFENAC remains the US FDA Preferred Term for this commodity. Aceclofenac bears US NLM identifiers UMLS ID C0050403 and NCI Concept Code C80534. SMILES: CLC1C(NC2C(CC(=O)OCC(=O)O)CCCC2)C(CL)CCC1.